WHAT'S NEW -- November 1998

Treatment to Alleviate Pain of Chronic Shingles
Pain Treatment -- Efficacy of Homeopathic Arnica 30X
Health Care Professionals: Articles on Understanding Pain
Back to Archive

Treatment to Alleviate Pain of Chronic Shingles

A novel treatment for postherpetic neuralgia has been shown to alleviate the pain of chronic shingles in a majority of sufferers. A TOPICAL LIDOCAINE PATCH has been studied in the United States at the University of Washington School of Medicine and University of California San Francisco School of Medicine. The patches are applied directly to the painful region on a daily basis where they work directly on the damaged nerves underlying the painful skin. A significant advantage to these patches is that no significant amount of lidocaine enters the bloodstream. Patients have been using the patches successfully for up to 5 years. The TOPICAL LIDOCAINE PATCH is manufactured by Hind Health Care, Inc. (San Jose, California) and is pending FDA approval.

Pain Treatment -- Efficacy of Homeopathic Arnica 30X

A well-controlled study assessed the efficacy of HOMEOPATHIC ARNICA 30X for the treatment of muscle soreness pain associated with long-distance running. The placebo controlled drug trial was completed by 400 runners. The study concluded that this homeopathic remedy was ineffective and not better than placebo.
Vickers et al. Clin J Pain 1998;14:227-231

Health Care Professionals: Articles on Understanding Pain

A recent article in the journal "Neurology" described the pathological study of muscles, nerves, and blood vessels from limbs of persons with severe chronic Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy). The results of this small study demonstrated consistent changes in the muscles which appeared to be due to ischemia (not enough oxygen), similar to changes seen in some patients with diabetes. To the investigators' surprise, no consistent changes were seen in these patients' peripheral nerves. While very interesting, this study needs to be put in proper perspective. First, these patients were not typical CRPS patients, but rather had severe refractory disease--which is not common. Second, while the investigators looked closely for "structural abnormalities", i.e., changes that can be seen by microscopy, they did not evaluate changes in neurochemicals, abnormal connections made between nerves, nor alterations in the central nervous system (spinal cord and brain).
Van der Laan et al. Neurology 1998;51:20-25

A very interesting and thought-provoking article was recently published by pain psychiatrist and philosopher, Mark Sullivan, MD, Ph.D. In his article "The Problem of Pain in the Clinicopathological Method", he points out that the vast majority of symptoms that bring patients to a doctor does not result in a "tissue diagnosis." In other words, in only one in five patients is a doctor able to make a definite diagnosis, even after the doctor completes a medical history, performs a physical examination, and obtains the results of laboratory testing. Yet doctors are still trained, as Dr. Sullivan states, "to be search-and-destroy engines for disease." When assessing and assisting a person in pain, the physician must not rely only on currently available methods to "find the source of the pain" before treatment is offered. The physician must not divide pain into "organic" and "nonorganic." The physician must be a scientist but not forget the art of healing. This poignant and well-written article is a must for physician and patient alike.
Sullivan M. Clinical Journal of Pain 1998;14:201

BACK TO ARCHIVE OF "WHAT'S NEW"

  ©2000 Continuum Health Partners, Inc.
Disclaimer